The present invention aims to provide an agent for the prophylaxis or treatment of diabetes, which has a superior hypoglycemic action, and is associated with a fewer side effects such as body weight gain and the like.
The present invention relates to an agent for the prophylaxis or treatment of diabetes comprising a compound represented by the formula:
wherein each symbol is as defined in the description, or a salt thereof, or a prodrug thereof.
[EN] SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS NADPH OXIDASE INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES BICYCLIQUES SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE NADPH OXYDASE
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2018203298A1
公开(公告)日:2018-11-08
The present application relates to substituted fused heteroaryl and heterocyclic compounds, useful as nicotinamide adenine dinucleotide phosphate oxidase inhibitors (NADPH oxidase inhibitors), processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by NADPH oxidase. (Formula I)
The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein Q, R1 and R2 areas defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.
Benzoylpyrazoles of the formula (I) and their use as herbicides are described.
1
In the formula (I), R
1
, R
2
, R
3
, R
4
, and R
5
are various radicals and n is from 0 to 2.